Business Wire

FourKites Launches New Unified Customer Interface - The First Solution to Deliver End-to-end Supply Chain Visibility in a Single Platform

14.9.2022 16:20:00 EEST | Business Wire | Press release

Share

Leading supply chain visibility company FourKites today announced a major platform upgrade that enables organisations to more easily leverage critical supply chain visibility data across their enterprise. The new release creates seamless integration between real-time transportation visibility and facility-specific data — across all modes — providing actionable insights that drive efficiencies and prevent disruptions across the end-to-end supply chain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220901005394/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites launches new unified Customer Interface - the first solution to deliver End-to-end supply chain visibility in a single platform (Photo: Business Wire)

With these latest enhancements, data automatically syncs between the platform’s real-time transportation tracking, Appointment Manager and Dynamic Yard ® applications to deliver faster, more contextualised multimodal insights that drive ROI across all teams. Some examples of these actionable insights include:

  • Transportation managers can reprioritise schedules in advance based on appointment times displayed alongside the shipment’s corresponding ETA
  • Warehouse leaders can automatically check in and check out freight arriving at a point with geofence tracking, enabling accurate record-keeping of facility operations
  • Supply chain executives can accurately track landed costs for shipments in one single view, including multimodal detention charges, ocean demurrage, transloading and facility dwell
  • Inventory planners have a full view of on-hand and in-transit inventory to better plan production schedules, or outbound cuts to reduce penalties and eliminate expedites
  • Supply chain and warehouse executives can optimise facility schedules based on ocean port of call ETAs to ensure the fastest throughput of ocean containers and minimise truckload traffic

Together, these improvements give users across the enterprise easy access to the critical supply chain information they need to drive faster resolutions, proactively manage exceptions, and provide better reporting to their supply chain partners.

“Today represents a major step toward helping large enterprises leverage supply chain visibility across their business,” said FourKites’ Founder and CEO Mathew Elenjickal. “We have customers with hundreds and thousands of users, so as we continue to drive innovation in the industry, we remain focused on maximising usability and value for our customers. Giving them the ability to see all of their data tightly integrated and automated in one platform, across all modes and geographies, is the best way to ensure ROI.”

FourKites was recently named a Leader in the 2022 Gartner ® Magic Quadrant™ for Real-Time Transportation Visibility Platforms, positioned the furthest for its Completeness of Vision. In addition, the company scored the highest for Fortune 500 businesses with complex needs in Gartner’s companion report, the 2022 Gartner® Critical Capabilities for Real-Time Transportation Visibility Platforms. In that analysis, FourKites ranked #1 in three of the five most advanced Use Cases.

Praise for FourKites’ User Interface from Gartner Peer Reviews:

  • FourKites has been a great company to partner with. They have a strong customer service focus and tend to take product feedback through development to production surprisingly quickly. Their core tracking platform, while sophisticated, is remarkably intuitive and they seem to have an eye for end user experience in everything they produce. - Transportation Sr. Manager, Manufacturing
  • FourKites continues to excel and impress me with their ability to deliver tools that are useful and support our account in a way that is customer first. In working with them, they have been able to roll out coverage in multiple countries, manage the work, and enhance their tool along the way. I'm very impressed with their product and the agility in delivery. - Logistics Strategy Analyst, Manufacturing
  • We have been beyond happy with how FourKites has enabled us to scale efficiently. Their service and customer support are excellent and the integration has allowed us to become much more efficient. - Innovations And Systems Manager, Transportation
  • Easy and a ton of information made available with a click of the mouse. Within a few moments I can get a real time overview of loads. - Inventory Administrator, Food & Beverage
  • The platform is really friendly and easy to use, with a lot of potential to increase our visibility and help us be more agile. - Latin America Transportation Sr. Manager, Manufacturing
  • This platform is great in providing our supply chains teams and stores with real-time visibility on loads across the network. It is intuitive, user friendly, and a great and powerful tool to provide meaningful insights. - Supply Chain Rotational Analyst, Retail

About FourKites

FourKites® is the largest supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.8 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
European PR Director FourKites
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye